Comparison of lupus anticoagulants (▪) and anticardiolipin antibodies (■) for their association with thrombosis: analysis of 5 studies on 753 patients and 234 controls.

Odds ratios with 95% CI are grouped according to the site and type of thrombosis and the study design.*Studies in systemic lupus erythematosus. ns indicates not significant; and Ref, reference.